naftopidil has been researched along with Prostatism in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
| Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P | 1 |
| Fink, HA; Garimella, PS; Macdonald, R; Wilt, TJ | 1 |
| Honda, S; Iwata, S; Kawachi, Y; Maruyama, O; Noto, K; Sakurai, T; Sugimura, S | 1 |
| Araki, K; Awa, Y; Egoshi, K; Ichikawa, T; Komiya, A; Mikami, K; Nakatsu, H; Naya, Y; Ohki, T; Onishi, T; Ota, S; Sato, N; Suzuki, H | 1 |
3 review(s) available for naftopidil and Prostatism
| Article | Year |
|---|---|
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics | 2016 |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Prostatism; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin | 2009 |
1 trial(s) available for naftopidil and Prostatism
| Article | Year |
|---|---|
Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective study.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatism; Quality of Life; Surveys and Questionnaires | 2010 |
1 other study(ies) available for naftopidil and Prostatism
| Article | Year |
|---|---|
Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Naphthalenes; Pilot Projects; Piperazines; Prognosis; Prostatic Hyperplasia; Prostatism; Retrospective Studies; Sulfonamides; Tamsulosin; Time Factors | 2010 |